| Q37108203 | A retrospective analysis of hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis |
| Q36824877 | A retrospective study on intensity-modulated radiation therapy combined with chemotherapy after D2 radical surgery for gastric carcinoma |
| Q37149160 | Accomplishments in 2007 in the management of localized gastric cancer |
| Q26858776 | Adjuvant Chemoradiation Therapy in Gastric Cancer: Critically Reviewing the Past and Visualizing the Next Step Forward |
| Q36671309 | Adjuvant and neoadjuvant therapy for gastric cancer using epirubicin/cisplatin/5-fluorouracil (ECF) and alternative regimens before and after chemoradiation |
| Q37076527 | Adjuvant and preoperative therapy for localized gastric cancer. |
| Q44102379 | Adjuvant chemoradiotherapy after D2 resection in gastric cancer: a single-center observational study |
| Q27022943 | Adjuvant chemoradiotherapy in gastric adenocarcinoma: about 34 cases and review of the literature |
| Q43631942 | Adjuvant radiochemotherapy in the treatment of completely resected, locally advanced gastric cancer |
| Q95596141 | Adjuvant therapy in resectable gastric cancer-the CRITICS trial |
| Q34015030 | Aggressive locoregional surgical therapy for gastric peritoneal carcinomatosis |
| Q43733166 | Are biomarkers correlated with recurrence patterns in patients with resectable gastric adenocarcinoma |
| Q35193685 | Chemoradiation for resectable gastric cancer |
| Q43526800 | Chemoradiotherapy in the adjuvant treatment of gastric adenocarcinomas: real progress? |
| Q35480864 | Clinical outcomes according to primary treatment in gastric cancer patients with peritoneal seeding. |
| Q80629676 | Clinical stage after preoperative chemoradiation is a better predictor of patient outcome than the baseline stage for localized gastric cancer |
| Q37609288 | Clinical value of hematologic test in predicting tumor response to neoadjuvant chemotherapy with esophageal squamous cell carcinoma |
| Q37560037 | Comparing Efficacy of Preoperative neo-Adjuvant Chemotherapy and Surgery versus Surgery Alone in Patients with Resectable Gastroesophageal Cancer |
| Q43011811 | Comparison of intensity-modulated radiotherapy and 3-dimensional conformal radiotherapy as adjuvant therapy for gastric cancer |
| Q36359981 | Computed tomography-guided permanent brachytherapy for locoregional recurrent gastric cancer |
| Q37610103 | Continuous low-dose irradiation by I-125 seeds induces apoptosis of gastric cancer cells regardless of histological origin. |
| Q37076597 | Crossroads in the combined-modality management of gastroesophageal junction carcinomas. |
| Q35097713 | Curative treatment of gastric cancer: towards a multidisciplinary approach? |
| Q36411935 | Efficacy of paclitaxel-based doublet regimens combining with intraperitoneal chemotherapy for advanced gastric cancer with peritoneal metastasis |
| Q37697546 | Extent of lymphadenectomy and perioperative therapies: two open issues in gastric cancer |
| Q36313942 | Five-year Survival Rate for Gastric Cancer in Yazd Province, Central Iran, from 2001 to 2008. |
| Q35206807 | Gastric cancer: advances in adjuvant and adjunct therapy |
| Q77711975 | Gastric surgical adjuvant radiotherapy consensus report: rationale and treatment implementation |
| Q34802936 | Gene expression signature-based prognostic risk score in gastric cancer |
| Q89303203 | Human epidermal growth factor receptor 2-, epidermal growth factor receptor-, and mesenchymal epithelial transition factor-positive sites of gastric cancer using surgical samples |
| Q33410889 | Image-guided intensity-modulated radiotherapy for patients with locally advanced gastric cancer: a clinical feasibility study |
| Q36544341 | Incidence, natural history, and patterns of locoregional recurrence in gastric cancer patients treated with preoperative chemoradiotherapy |
| Q37250569 | Indirect comparison showed survival benefit from adjuvant chemoradiotherapy in completely resected gastric cancer with d2 lymphadenectomy |
| Q36295443 | Influence of interfraction motion on margins for radiotherapy of gastric cancer |
| Q40761194 | Intraoperative and early postoperative chemotherapy into the abdominal cavity using gemcitabine may prevent postoperative occurence of peritoneal carcinomatosis |
| Q35677756 | Intraoperative radiotherapy in the multimodality approach to gastric cancer |
| Q64076485 | Korean Practice Guideline for Gastric Cancer 2018: an Evidence-based, Multi-disciplinary Approach |
| Q41992203 | Localized gastric or gastroesophageal cancer - chemoradiation is a pertinent component of adjuvant treatment for patients at high risk of relapse. |
| Q92617955 | Normothermic intraperitoneal chemotherapy long term (NIPEC-LT) in the management of peritoneal surface malignancy, an overview |
| Q73682704 | Patterns of failure and long-term results in high-risk resected gastric cancer treated with postoperative radiotherapy with or without intraoperative electron boost |
| Q36626030 | Patterns of failure in gastric carcinoma after D2 gastrectomy and chemoradiotherapy: a radiation oncologist's view |
| Q35922065 | Patterns of initial recurrence in completely resected gastric adenocarcinoma |
| Q59810595 | Patterns of regional nodal relapse after D2 lymphadenectomy in gastric cancer: rethinking the target volume |
| Q30491067 | Phase II Study of Adjuvant Chemoradiotherapy Using Docetaxel/Cisplatin/5-Fluorouracil Before and After Intensity-modulated Radiotherapy With Concurrent Docetaxel in Patients With Completely (R0) Resected Gastric Carcinoma |
| Q37127154 | Planning comparison between standard and conformal 3D techniques in post-operative radiotherapy of gastric cancer: a systematic review. |
| Q77297096 | Positive peritoneal cytology predicts unresectability of pancreatic adenocarcinoma |
| Q44207263 | Postoperative adjuvant chemoradiation in completely resected locally advanced gastric cancer |
| Q34255467 | Postoperative adjuvant chemoradiotherapy in D2-dissected gastric cancer: is radiotherapy necessary after D2-dissection? |
| Q38076429 | Postoperative adjuvant radiotherapy for patients with gastric adenocarcinoma |
| Q35560032 | Postoperative chemoradiation for resected gastric cancer--is the Macdonald Regimen Tolerable? a retrospective multi-institutional study |
| Q36431624 | Preliminary results of the use of intraperitoneal carbon-adsorbed mitomycin C in intra-abdominal malignancy |
| Q36555935 | Preoperative chemoradiotherapy for locally advanced gastric cancer |
| Q77358670 | Preoperative positivity of serum tumor markers is a strong predictor of hematogenous recurrence of gastric cancer |
| Q35435610 | Preventing prolonged post-operative ileus in gastric cancer patients undergoing gastrectomy and intra-peritoneal chemotherapy |
| Q33430940 | Prospective phase II trial of pazopanib plus CapeOX (capecitabine and oxaliplatin) in previously untreated patients with advanced gastric cancer |
| Q57130153 | Prospective randomized trial of early postoperative intraperitoneal chemotherapy as an adjuvant to resectable gastric cancer |
| Q35419356 | Radiotherapy patterns of care in gastric adenocarcinoma: a single institution experience |
| Q83450974 | Randomized clinical trial of adjuvant chemotherapy with intraperitoneal and intravenous cisplatin followed by oral fluorouracil (UFT) in serosa-positive gastric cancer versus curative resection alone: final results of the Japan Clinical Oncology Gro |
| Q34590788 | Recent developments in the treatment of gastric carcinoma |
| Q74604747 | Response to neoadjuvant chemotherapy best predicts survival after curative resection of gastric cancer |
| Q73508634 | Results of irradiation or chemoirradiation following resection of gastric adenocarcinoma |
| Q73403899 | Results of irradiation or chemoirradiation for primary unresectable, locally recurrent, or grossly incomplete resection of gastric adenocarcinoma |
| Q33403352 | Retrospective analysis of treatment outcomes after postoperative chemoradiotherapy in advanced gastric cancer |
| Q41370888 | Retrospective assessment of patterns of recurrence relative to radiotherapy volumes for adjuvant conformal chemoradiotherapy in gastric cancer. |
| Q60692463 | Stage-Specific Survival Differences Associated with Postoperative Radiotherapy for Gastrointestinal Cancers |
| Q56786790 | Surgical pathology stage by American Joint Commission on Cancer criteria predicts patient survival after preoperative chemoradiation for localized gastric carcinoma |
| Q42008826 | Surgical resection of late solitary locoregional gastric cancer recurrence in stomach bed |
| Q55381751 | Survival prediction of gastric cancer patients by Artificial Neural Network model. |
| Q55069791 | The NanoString-based multigene assay as a novel platform to screen EGFR, HER2, and MET in patients with advanced gastric cancer. |
| Q34867208 | The result of conversion surgery in gastric cancer patients with peritoneal seeding |
| Q47094879 | Time to local recurrence as a predictor of survival in unrecetable gastric cancer patients after radical gastrectomy |
| Q71726695 | Treatment of adenocarcinoma of the stomach with resection, intraoperative radiotherapy, and adjuvant external beam radiation: a phase II study from Radiation Therapy Oncology Group 85-04 |
| Q37722602 | Treatment options for surgically resectable gastric cancer |
| Q34638268 | Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection |
| Q53167144 | Value of FGFR2 expression for advanced gastric cancer patients receiving pazopanib plus CapeOX (capecitabine and oxaliplatin). |
| Q81019721 | When is curative gastrectomy justified for gastric cancer with positive peritoneal lavage cytology but negative macroscopic peritoneal implant? |
| Q77919354 | [Concomitant chemoradiotherapy in the therapeutic strategy of adenocarcinoma of the exocrine pancreas and stomach] |
| Q82728816 | [Gastric cancer] |
| Q77200764 | [Target volume in radiotherapy of gastric adenocarcinoma] |